10X Genomics Inc
TXG
$76.60-0.48%
End of day · as of Sep 19, 2026, 10:01 AM ET
Mkt cap
$4.08B
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$642.82M
EPS (H1 2026)
$-0.24
Gross Margin (FY2025)
69.05%
Profit Margin (FY2025)
-6.77%
Beta
N/A
Div yield
N/A
Sector
Healthcare
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Latest reported TXG revenue for 2025-12-31 was $642.8M. Net income was -$43.5M. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. TXG currently screens at market cap $4.08B.
Use this TXG research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TXG income, balance, and cash tables.
10X Genomics Inc (TXG) is a health information services company in the Healthcare sector.
Latest cached 10X Genomics Inc (TXG) revenue for Dec 31, 2025 was $642.8M. Net income was -$43.5M. Statements: https://lician.com/financials/txg
10X Genomics Inc (TXG) market capitalization is $4.08B on the latest cached snapshot.
10X Genomics Inc (TXG) cached previous close $76.97; day range $75.21 – $78.08; volume 2,881,918. Session quote: https://lician.com/quote/txg
10X Genomics Inc (TXG) latest cached earnings event is "TXG earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TXG filing is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/txg